Carbon dioxide (CO2) as an alternative contrast agent in percutaneous transluminal angioplasty procedures for chronic limb-threatening ischemia patients with chronic kidney disease
DOI:
https://doi.org/10.21776/ub.hsj.2024.005.04.16Keywords:
Peripheral artery disease, Chronic limb threatening ischemia, Chronic limb ischemia, Chronic kidney disease, Contrast induced nephropathy, CO2 angiographyAbstract
Background: Chronic limb-threatening ischemia (CLTI) is a very morbid illness that significantly reduces quality of life. The severity of this disease may necessitate revascularization or amputation.Arteriography is frequently performed for the planning of revascularization. Patients with compromised kidney function need alternative contrast agents.CO2 may be utilized in lower extremity vascular diagnostics and intervention, especially in patients at risk for contrast-induced nephropathy (CIN).
Case Illustration: An 80-year-old female with bilateral leg pain and leg swelling had an ulcer on her toe for 2 weeks. She had a history of intermittent claudication for 1 year, hypertension for 5 years, kidney stones for 2 years, and chronic kidney disease for 1 year. She underwent an ECG, laboratory, USG, DUS, and CT-angiography examination. From her laboratory result, her initial creatinine was 5.02 mg/dL (eGFR 8 mL/m/1.73 m2). After good hydration, it became 1.28 mg/dL (eGFR 39 mL/m/1.73 m2). After a CT-angiography procedure, her creatinine level was increased (3.7 mg/dL; eGFR 10.9 mL/m/1.73 m2). She was diagnosed with CLTI Rutherford V Fontain 3 left lower extremity. She suggested doing an angioplasty procedure with a safer contrast agent. An angioplasty procedure was done at RSSA Malang with CO2 contrast. After the procedure, her leg pain improved, and her creatinine didn’t elevate.
Conclusion: CO2 angiography might be used as a safe alternative contrast medium in patients with CLTI, which benefits the preservation of renal function and prevents limb amputations.
References
Conte MS, Bradbury AW, Kolh P, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 2019;58(1):S1-S109.e33. doi:10.1016/j.ejvs.2019.05.006
Abu Dabrh AM, Steffen MW, Undavalli C, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(6):1642-1651. e3. doi:10.1016/j.jvs.2015.07.065
Santilli JD, Santilli SM, Chronic Critical Limb Ischemia: Diagnosis, Treatment, and Prognosis, Vol. 59,. https://www.aafp.org/pubs/afp/issues/1999/0401/p1899.html
Kinlay S. Management of critical limb ischemia. Circ Cardiovasc Interv. 2016;9(2). doi:10.1161/CIRCINTERVENTIONS.115.001946
Serra R, Bracale UM, Ielapi N, et al. The impact of chronic kidney disease on peripheral artery disease and peripheral revascularization. Int J Gen Med. 2021;14:3749-3759. doi:10.2147/IJGM.S322417
Cho KJ, Carbon Dioxide Angiography: Scientific Principles and Practice. Vasc Specialist Int. 2015;31(3):67-80. doi:10.5758/vsi.2015.31.3.67
Garimella PS, Hirsch AT. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014;21(6):460–471. doi:10.1053/j.ackd.2014.07.005
Kyung J. Cho, MFFCEECLM. Carbon Dioxide Angiography Overview. https://emedicine.medscape.com/article/423121-overview
Aboyans V, Ricco JB, Bartelink MLEL, et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. doi:10.1093/eurheartj/ehx095
Gupta A, Dosekun AK, Kumar V. Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy. World J Cardiol. 2020;12(2):76–89. doi:10.4330/wjc.v12.i2.76
Bourrier M, Ferguson TW, Embil JM, Rigatto C, Komenda P, and Tangri N. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD. American Journal of Kidney Diseases. 2020;75(5):705-712. doi:10.1053/j.ajkd.2019.08.028
Shams E, Mayrovitz HN. Contrast-Induced Nephropathy: A Review of Mechanisms and Risks. Cureus. Published online May 4, 2021. doi:10.7759/cureus.14842
Farber A. Chronic Limb-Threatening Ischemia. New England Journal of Medicine. 2018;379(2):171–180. doi:10.1056/nejmcp1709326
Young M., Affiliations JM. Carbon Dioxide Angiography Continuing Education Activity. https://www.ncbi.nlm.nih.gov/books/NBK534244/?report=printable
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).